1. Home
  2. FSSL vs VSTM Comparison

FSSL vs VSTM Comparison

Compare FSSL & VSTM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo FS Specialty

FSSL

FS Specialty

HOLD

Current Price

$11.57

Market Cap

884.4M

Sector

Finance

ML Signal

HOLD

VSTM

Verastem Inc.

HOLD

Current Price

$9.93

Market Cap

731.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FSSL
VSTM
Founded
2010
2010
Country
United States
United States
Employees
N/A
N/A
Industry
Finance/Investors Services
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
884.4M
731.8M
IPO Year
2025
2011

Fundamental Metrics

Financial Performance
Metric
FSSL
VSTM
Price
$11.57
$9.93
Analyst Decision
Strong Buy
Analyst Count
0
10
Target Price
N/A
★ $17.22
AVG Volume (30 Days)
248.1K
★ 4.7M
Earning Date
01-01-0001
11-05-2026
Dividend Yield
★ 15.05%
N/A
EPS Growth
N/A
★ 17.49
EPS
★ N/A
N/A
Revenue
N/A
★ $30,914,000.00
Revenue This Year
N/A
$260.03
Revenue Next Year
N/A
$43.01
P/E Ratio
$9.70
★ N/A
Revenue Growth
N/A
★ 209.14
52 Week Low
$10.75
$3.43
52 Week High
$14.49
$10.82

Technical Indicators

Market Signals
Indicator
FSSL
VSTM
Relative Strength Index (RSI) 48.36 65.25
Support Level $11.31 $5.41
Resistance Level $11.92 N/A
Average True Range (ATR) 0.23 0.89
MACD 0.02 0.17
Stochastic Oscillator 45.69 89.77

Price Performance

Historical Comparison
FSSL
VSTM

About FSSL FS Specialty

FS Specialty Lending Fund is a United States-based externally managed, non-diversified, closed-end management investment company. The company's investment objectives are to generate current income and, to a lesser extent, long-term capital appreciation by investing mainly in private and public credit in a broad set of industries, sectors, and sub-sectors. Its investment policy is to invest mainly in a portfolio of secured and unsecured floating and fixed-rate loans, bonds, and other types of credit instruments, which, under normal circumstances, will represent at least eighty percent of the Company's total assets.

About VSTM Verastem Inc.

Verastem Inc is late-stage development biopharmaceutical company, committed to advancing new medicines for patients battling cancer. Its pipeline is focused on novel anticancer agents that inhibit critical signaling pathways in cancer that promote cancer cell survival and tumor growth, particularly RAF/MEK inhibition and FAK inhibition.

Share on Social Networks: